SummaryThe RNA‐guided Cas9 system is a versatile tool for genome editing. Here, we established a RNA‐guided endonuclease (RGEN) system as an in vivo desired‐target mutator (DTM) in maize to reduce the linkage drag during breeding procedure, using the LIGULELESS1 (LG1) locus as a proof‐of‐concept. Our system showed 51.5%–91.2% mutation frequency in T0 transgenic plants. We then crossed the T1 plants stably expressing DTM with six diverse recipient maize lines and found that 11.79%–28.71% of the plants tested were mutants induced by the DTM effect. Analysis of successive F2 plants indicated that the mutations induced by the DTM effect were largely heritable. Moreover, DTM‐generated hybrids had significantly smaller leaf angles that were reduced more than 50% when compared with that of the wild type. Planting experiments showed that DTM‐generated maize plants can be grown with significantly higher density and hence greater yield potential. Our work demonstrate that stably expressed RGEN could be implemented as an in vivo
DTM to rapidly generate and spread desired mutations in maize through hybridization and subsequent backcrossing, and hence bypassing the linkage drag effect in convention introgression methodology. This proof‐of‐concept experiment can be a potentially much more efficient breeding strategy in crops employing the RNA‐guided Cas9 genome editing.
Treatment of Staphylococcus aureus infections continues to be a challenge due to antimicrobial resistance. Endogenous antimicrobial peptides may offer a new option for treating S. aureus infections but several factors limit their clinical utility. Herein, we studied the activity of the antimicrobial peptide LL-37 and two truncated derivatives, LL-13 and LL-17 alone and in combination with vancomycin against a range of drug-resistant S. aureus strains including methicillin resistant S. aureus (MRSA) and vancomycin resistant S. aureus (VRSA) strains in vitro. When used with vancomycin, LL-13 and LL-17 displayed synergy against VRSA and showed the ability to restore sensitivity to vancomycin after pretreatment. In addition, LL-13 and LL-17 showed a strong ability to inhibit S. aureus biofilm production. LL-37 derivatives may be useful in treating infections that are resistant to vancomycin or in scenarios where biofilm formation is a concern.
Extracting features from sensing data on edge devices is a challenging application for which deep neural networks (DNN) have shown promising results. Unfortunately, the general micro-controller-class processors which are widely used in sensing system fail to achieve real-time inference. Accelerating the compute-intensive DNN inference is, therefore, of utmost importance. As the physical limitation of sensing devices, the design of processor needs to meet the balanced performance metrics, including low power consumption, low latency, and flexible configuration. In this paper, we proposed a lightweight pipeline integrated deep learning architecture, which is compatible with open-source RISC-V instructions. The dataflow of DNN is organized by the very long instruction word (VLIW) pipeline. It combines with the proposed special intelligent enhanced instructions and the single instruction multiple data (SIMD) parallel processing unit. Experimental results show that total power consumption is about 411 mw and the power efficiency is about 320.7 GOPS/W.
With the development of deep learning technologies and edge computing, the combination of them can make artificial intelligence ubiquitous. Due to the constrained computation resources of the edge device, the research in the field of on-device deep learning not only focuses on the model accuracy but also on the model efficiency, for example, inference latency. There are many attempts to optimize the existing deep learning models for the purpose of deploying them on the edge devices that meet specific application requirements while maintaining high accuracy. Such work not only requires professional knowledge but also needs a lot of experiments, which limits the customization of neural networks for varied devices and application scenarios. In order to reduce the human intervention in designing and optimizing the neural network structure, multi-objective neural architecture search methods that can automatically search for neural networks featured with high accuracy and can satisfy certain hardware performance requirements are proposed. However, the current methods commonly set accuracy and inference latency as the performance indicator during the search process, and sample numerous network structures to obtain the required neural network. Lacking regulation to the search direction with the search objectives will generate a large number of useless networks during the search process, which influences the search efficiency to a great extent. Therefore, in this paper, an efficient resource-aware search method is proposed. Firstly, the network inference consumption profiling model for any specific device is established, and it can help us directly obtain the resource consumption of each operation in the network structure and the inference latency of the entire sampled network. Next, on the basis of the Bayesian search, a resource-aware Pareto Bayesian search is proposed. Accuracy and inference latency are set as the constraints to regulate the search direction. With a clearer search direction, the overall search efficiency will be improved. Furthermore, cell-based structure and lightweight operation are applied to optimize the search space for further enhancing the search efficiency. The experimental results demonstrate that with our method, the inference latency of the searched network structure reduced 94.71% without scarifying the accuracy. At the same time, the search efficiency increased by 18.18%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.